Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2008;39:2902-2909
Published online before print July 24, 2008, doi: 10.1161/STROKEAHA.107.511261
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
39/10/2902    most recent
STROKEAHA.107.511261v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiteley, W.
Right arrow Articles by Sandercock, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteley, W.
Right arrow Articles by Sandercock, P.
Related Collections
Right arrow Other diagnostic testing
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction

(Stroke. 2008;39:2902.)
© 2008 American Heart Association, Inc.


Progress Review

Blood Biomarkers in the Diagnosis of Ischemic Stroke

A Systematic Review

William Whiteley, MRCP; Mei-Chiun Tseng, PhD Peter Sandercock, FRCPE

From the Division of Clinical Neurosciences (W.N.W., P.S.), University of Edinburgh, UK; and National Sun Yat-Sen University (M.-C.T.), Taiwan.

Correspondence to W.N. Whiteley, MRCP, Department of Clinical Neurosciences, Western General Hospital, Edinburgh EH4 2XU, UK. E-mail william.whiteley{at}ed.ac.uk

Background and Purpose— The diagnosis of ischemic stroke can be difficult. CT may be normal in the early stages of ischemic stroke or in patients with minor symptoms and MR is not always possible. Many blood markers have been proposed for the diagnosis of stroke in the acute setting.

Methods and Results— We have systematically reviewed the diagnostic literature and found 21 studies testing 58 single biomarkers and 7 panels of several biomarkers. Although all show either a high sensitivity or specificity, there are limitations in the design and reporting of all the studies that mean no biomarker can be recommended for use in clinical practice.

Conclusions— We make recommendations for the design and reporting of studies of diagnostic blood biomarkers in stroke.


Key Words: biomarker • stroke • hemorrhagic stroke • ischemic stroke • diagnosis




This article has been cited by other articles:


Home page
Clin. Chem.Home page
A. K. Saenger and R. H. Christenson
Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment
Clin. Chem., January 1, 2010; 56(1): 21 - 33.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. Foerch, J. Montaner, K. L. Furie, M. M. Ning, and E. H. Lo
Invited Article: Searching for oracles?: Blood biomarkers in acute stroke
Neurology, August 4, 2009; 73(5): 393 - 399.
[Abstract] [Full Text] [PDF]